Enterococcal superinfection and colonization with aztreonam therapy
- 1 August 1984
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 26 (2), 280-282
- https://doi.org/10.1128/aac.26.2.280
Abstract
Patients were given aztreonam (SQ 26,776) parenterally for the treatment of various gram-negative infections. During or shortly after therapy, 8 (17.8%) of 45 patients became infected with or colonized by enterococcus. These eight cases included eight urinary tract isolates; one of these cases subsequently developed bacteremia. Five patients required further antimicrobial therapy directed against enterococcus. Patients receiving aztreonam are at risk for the development of enterococcal superinfection or colonization.Keywords
This publication has 9 references indexed in Scilit:
- Pharmacokinetics and tissue penetration of azthreonamAntimicrobial Agents and Chemotherapy, 1982
- Enterococcal Infections in Patients Treated with MoxalactamClinical Infectious Diseases, 1982
- Enterococcal Superinfection and Colonization After Therapy with Moxalactam, a New Broad-Spectrum AntibioticAnnals of Internal Medicine, 1981
- Pharmacokinetics of the monobactam SQ 26,776 after single intravenous doses in healthy subjectsJournal of Antimicrobial Chemotherapy, 1981
- Antibacterial activity of a monocyclic -lactam SQ 26,776Journal of Antimicrobial Chemotherapy, 1981
- SQ 26,776: in-vitro antibacterial activity and susceptibility to -lactamasesJournal of Antimicrobial Chemotherapy, 1981
- Monobactams--monocyclic -lactam antibiotics produced by bacteriaJournal of Antimicrobial Chemotherapy, 1981
- Colonization, suprainfection and superinfection: major microbiologic and clinical problems.1977
- Antibiotic-induced SuprainfectionThe Journal of Infectious Diseases, 1969